However, be cautious about sudden position changes during exercise to avoid dizziness
Results of RWS are in line with data from RCT
The expiration of patents opens the door for multiple generic manufacturers to produce lower-cost versions of the medication, which could greatly reduce prices and expand patient access beyond the expensive branded options
These results highlight semaglutides early action on decreasing major cardiovascular events, with significant benefits already evident by the first six months, and for some, even earlier, even before any major weight loss and before most patients would have been titrated to their full target dose of 2.4 mg, lead author Jorge Plutzky, MD, director of preventive cardiology with Brigham and Womens Hospital, said in a statement
The pharmacokinetic argument is the strongest